Ibrutinib skin toxicities: report of two cases.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of cutaneous pathology"
DOI: 10.1111/cup.14160
Abstract: Ibrutinib is a Bruton tyrosine kinase inhibitor used to treat many hematologic conditions, most commonly B-cell lymphomas and leukemias. Reportedly, skin rash is an adverse event in up to 27% of treated patients. Histopathologic description… read more here.
Keywords: toxicities report; report two; cases ibrutinib; ibrutinib skin ... See more keywords
Ibrutinib-related uveitis: A report of two severe cases.
Sign Up to like & getrecommendations! Published in 2021 at "European journal of ophthalmology"
DOI: 10.1177/11206721211001268
Abstract: INTRODUCTION Ibrutinib is a small-molecule drug approved for the treatment of haematological disorders and is known to be associated with visual disturbances, but uveitis has not yet been reported as an adverse effect of this… read more here.
Keywords: ibrutinib; treatment; cases ibrutinib; related uveitis ... See more keywords